Ulcerative (chronic) pancolitis
ICD-10 K51.0 is a used to indicate a diagnosis of ulcerative (chronic) pancolitis.
Ulcerative (chronic) pancolitis is a form of inflammatory bowel disease (IBD) characterized by chronic inflammation and ulceration of the colonic mucosa, affecting the entire colon. Clinically, patients may present with symptoms such as abdominal pain, diarrhea (often bloody), urgency, and weight loss. The disease can lead to complications such as toxic megacolon, perforation, and increased risk of colorectal cancer. The anatomy involved includes the entire colon, which is divided into the cecum, ascending colon, transverse colon, descending colon, and sigmoid colon. Disease progression can vary, with some patients experiencing intermittent flares and periods of remission. Diagnostic considerations include colonoscopy with biopsy, which helps confirm the diagnosis by revealing characteristic mucosal changes. Laboratory tests may also be performed to assess inflammation and rule out other conditions. Early diagnosis and management are crucial to prevent complications and improve the quality of life for affected individuals.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K51.0 specifically covers ulcerative pancolitis, which is characterized by inflammation and ulceration of the entire colon. It is important to differentiate it from other forms of ulcerative colitis that may affect only part of the colon.
K51.0 should be used when the clinical documentation indicates that the entire colon is affected by ulcerative colitis. If only a portion of the colon is involved, related codes such as K51.1 or K51.9 should be considered.
Documentation should include a detailed clinical history, results from colonoscopy and biopsy confirming pancolitis, and any relevant laboratory tests indicating inflammation. Treatment plans and follow-up notes should also be included.
